NN-429

Overview

NN-429 is a selective HDAC6 inhibitor. NN-429 induces apoptosis , increases the acetylation level of α-tubulin , and exhibits cytotoxicity against cancer cells. NN-429 is applicable to research related to acute myeloid leukemia, multiple myeloma and lymphoma.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Acute Myeloid Leukemia | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HDAC | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Microtubule/Tubulin

Product Information

• Catalog No.: HY-182649
• CAS No.: 2490284-32-5
• Molecular Formula: C17H15F5N2O4S
• Molecular Weight: 438.37
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source